Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AFactory

Financiado

Cerrado

THE FUTURE OF FOOD Disrupting protein production with microalgae

"By 2050, providing food for 10 billion people will become critical. Current protein sources cannot scale up without jeopardizing the environment. French start-up Kyanos has developed a disruptive plant-based protein production te... ver más

31/10/2019

Kyanos Biotech

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

KYANOS BIOTECHNOLOGIES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-10-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Kyanos Biotech

50.00K€ | Lider

GRUPO RODIO KRONSA

696.73K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RYC2021-031061-I Development of microalgae-based processes to increase the su... 236K€ Cerrado

ALEHOOP Biorefineries for the valorisation of macroalgal residual bi... 7M€ Cerrado

VegaAlga Sustainable agricultural eco system business and technologi... 2M€ Cerrado

ECO-LOGIC GREEN FARM Design of an agricultural greenhouse for intensive growing o... 4M€ Cerrado

IJC2018-035287-I Novel applications of cultured microalgae in agricultural an... 93K€ Cerrado

Biosolar Leaf Disrupting the food ingredient and protein markets: a breakt... 3M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2019-04-17
Fecha Fin: 2019-10-31

Líder del proyecto

KYANOS BIOTECHNOLOGIES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "By 2050, providing food for 10 billion people will become critical. Current protein sources cannot scale up without jeopardizing the environment. French start-up Kyanos has developed a disruptive plant-based protein production technology with no environmental downside. Its unlimited supply potential is in line with the food industry requirements. With unprecedented yields, cost effectiveness and health safety conditions, this industrial process, called ""Cyclotrophy"" caters for the growing market expectations for healthy, environmentally-friendly products. Cyclotrophy won the Most Novel Protein Process & IT award at the Protein Summit 2018. It boosts the production of microorganisms such as microalgae and eliminates the unpredictability and the contaminants that affect traditional microalgae production. The process relies on smarter, more compact and more efficient production infrastructure and takes 20 times less space for a similar output. A fully functional lab-scale pilot is already running using AFA microalgae (Aphanizomenon flos-aquae). Thanks to a partnership with Altran Group, Kyanos is now about to ramp-up to the industrial scale. The production capacity of the first factory is devised to quickly grow to reach 100 tonnes of AFA microalgae per year by 2023. Kyanos will first target the high-margin dietary supplements market before addressing the massive food-ingredients demand. Drawing on existing distribution channels and health prescription dynamics, the initial product, AFA microalgae powder, will be sold to global health supplements companies. Kyanos will initiate EU distribution from year 2 onwards. In 2023, exports throughout Europe will represent 95% of the production, presumably gaining a 10% market share and inducing up to 110 indirect job creations in France and Europe The objectives of the SMEi1 are: to secure full-scale design for the Cyclotrophy process scale-up; IP, FTO analysis and global market survey to schedule commercialization actions."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores